Evaluation of the role of dynamic 64-MDCT in the characterization and work up of breast cancer  by Wahab, Moustafa A. Kader A. & Abdel Kareem, Hoda
The Egyptian Journal of Radiology and Nuclear Medicine (2015) 46, 535–544Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLEEvaluation of the role of dynamic 64-MDCT in the
characterization and work up of breast cancerqq No disclosure of funding received for this work from any
organization. All authors have appraised the article and actively
contributed to the work. Moustafa A. Kader A. Wahab: Data
collection and image revision. Hoda Abdel Kareem: Final editing and
revision.
* Corresponding author at: El Minia University, El Minia, Egypt.
Tel.: +20 01123850453.
E-mail address: Moustafa18_1970@yahoo.com (M.A.K.A. Wahab).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2015.02.011
0378-603X  2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Moustafa A. Kader A. Wahab a,*, Hoda Abdel Kareem ba Department of Radiology, El Minia University, Egypt
b Department of Radiology, South Valley University, EgyptReceived 3 November 2014; accepted 24 February 2015
Available online 18 March 2015KEYWORD
64-MDCT breast cancer
diagnosisAbstract Background: Imaging of the breast is a vital component not only for breast cancer
screening, but also for diagnosis and treatment. Dynamic MDCT has a very promising role as
diagnostic tool in breast cancer patients.
Objective: This study aimed to emphasize the role of 64 MDCT in the work up of breast cancer.
Patients and methods: Between October 2012 to April 2014, 100 consecutive patients with suspi-
cious breast lesions underwent bilateral mammography, breast ultrasound and dynamic MDCT.
We evaluated the primary lesion morphology, pattern of enhancement with the time enhancement
curve, extensions, lymph nodal status, and metastasis in lung or chest wall. Tumor staged based on
the TNM classiﬁcation.
Results: In the studied 100 patients, MDCT detects 107 mass lesions; 64 were malignant and 43
were benign. The collected imaging data were correlated with the surgical and pathologic ﬁndings
in all patients. Breast dynamic MDCT with the pattern of the time enhancement curve was found to
be accurate in diagnosing and lesion characterization, the sensitivity was 93%, speciﬁcity was 89%,
and accuracy was 91%.
Conclusion: Dynamic MDCT should be considered as a feasible non invasive imaging tool for the
diagnosis and work up in patients with breast cancer.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer is the second leading cause of death in women.
Early detection is necessary to treat patients and improve their
chance for survival (1–3). Imaging of the breast is a vital com-
ponent not only for breast cancer screening, but also for diag-
nosis, evaluation, treatment and follow-up (4). Mammography
is the standard of reference for early detection of breast cancer
(5). Mammography is somewhat less sensitive and less speciﬁc
in women with dense breasts, in younger women and in women
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role in the assessment of breast masses. In recent years, ultra-
sound as an adjunct to mammography has improved accuracy
in the diagnosis of breast cancer. However, the effectiveness of
ultrasound test depends on the operator’s level of skill and
experience (7). Breast MRI is another excellent diagnostic tool
because it has a higher sensitivity compared to mammography;
however, there are some drawbacks, such as the cost and
lengthy scanning time. Breast MRI is not widely available
and some patients cannot do MRIs if they become claustro-
phobic or have a metallic implant such as a pacemaker (8).
Recent studies on the use of computed tomography (CT) tech-
nology for breast imaging have refocused the radiology com-
munity’s attention on the potential beneﬁts of breast CT.
Signiﬁcant advances in technology have enabled breast CT
to possibly become another alternative to mammography
and MRI for use in breast cancer screening. Breast CT may
be more accurate and providing other advantages, such as
being less intrusive than mammography and less intimidating
than MRI (9). Breast multi-detector CT (MDCT) imagers pro-
vide a 3D image of the breast and reduces the superimposition
of breast tissue, thus enabling improved tumor detections (10).
The main limitations to the breast CT was the high dose of X
ray exposure while the use of 64-detector CT machine and low
dose techniques reduce these limitations (11).
The aim of this study is to evaluate the role of 64-multide-
tector computed tomography in the characterization and work
up of breast cancer.
2. Materials and methods
2.1. Patients
This study was approved by the ethics committee of our insti-
tution during the period between January 2013 to April 2014.
It included 100 consecutive female patients with breast lump(s)
underwent mammography, ultrasound and MDCT of the
breast. The ages of the patients ranged from 28 to 71 years
(median ± 49 years). Written informed consent was obtained
from each patient prior to the examination and biopsy.
2.2. Inclusion criteria
In this study, cases were referred from the General Surgery
outpatient clinic for the assessment of suspected breast lump.
Some patients refer to CT examination as there are contra-
indication to MRI study, claustrophobic (6 patients) and car-
diac pacemakers (3 patients).
2.3. Exclusion criteria
Pregnancy, contra-indications for intravenous contrast, i.e.
iodine allergy, renal malfunction and previous allergic reaction
to I.V contrast.
2.4. Imaging protocol
1. Bilateral digital mammographic examination (except in
case of mastectomy): Standard medio-lateral oblique and
cranio-caudal views were taken to obtain a mirror image
of both sides.2. Bilateral breast U/S: Were performed on (Logiq P5, GE
Medical Systems, Korea) ultrasound machines with 7.5–
12 MHz-linear array transducer.
3. MDCT of the breast using 64-MDCT scanners
(Aquilion64; Toshiba Medical Systems Corporation,
Otawara, Japan) set with the following parameters: 3-mm
thickness, 120 kV, 50–70 mAs, 1-mm slice collimation.
Patients were scanned on the supine position; the scan
begins from the level of the axilla to the lower edge of the
breast, they asked to hold their breath 4 times, before
and 1, 3, and 8 min after an IV rapid bolus administration
of nonionic contrast material (100 mL) that infused at a
rate of 3.0 mL/s.
2.4.1. Post-imaging processing
Multiplanar, MIP and 3D reconstructions were done for the
evaluation of mass lesions. All detected lesions reviewed for
morphologic features and enhancement pattern. Also, we do
the time-density curve by putting the cursor over the solid
enhanced part of the lesion and plot the enhancement pattern
of the lesion on the 1st three minutes after contrast injection
using the software on the workstation. When washout occurs
within 1–3 min; it is called rapid washout, while, if washout
occurs later than 3 min it is called delayed washout. The curve
pattern is classiﬁed as; washout, plateau or rising.
2.5. Correlation between radiologic and histopathologic ﬁndings
To evaluate the diagnostic accuracy of MDCT in breast
masses, correlation with the histo-pathologic results was done
for all patients by either FNAB, core biopsy or surgical biopsy.
Statistical analysis was performed with the EPR validity test.
3. Results
This study included 100 consecutive female patients with 107
breast lumps, the clinical, radiological as well as pathological
ﬁndings, all were represented in tables and statistical forms.
3.1. Histopathological diagnosis
Of the 107 lesions, 64 were malignant; IDC was the most fre-
quent malignancy (45/64). Forty three lesions were benign of
which ﬁbro-adenoma was the most frequent pathology (33/
43) lesions (Table 1).
3.2. Clinical presentation
All patients were complaining of breast lump (s). Axillary L.Ns
were palpable ipsilaterally in 37 and bilaterally in 9 patients.
Nipple retraction with induration seen in 10 patients. Nipple
discharge was the complaint in 32 patients. Follow up of
lumpectomy scar done for 5 patients.
3.3. Mammographic diagnosis
According to the primary and secondary signs of malignancy,
classiﬁcation of the lesions was done to a category of benign
and malignant; out of 48 lesions that were diagnosed benign
Table 1 Analysis of the 107 lesions with histopathology
results.
Histo-pathology Number of lesions
Invasive duct Ca 45
Paget’s disease 6
Invasive lobular Ca 4
Mucinous Ca 4
Papillary Ca 3
Lymphoma 1
Metastases 1
Total malignant lesions 64
Fibro-adenoma 33
Abscess 3
Duct papilloma 5
Normal scar tissue 2
Total benign lesions 43
Evaluation of the role of dynamic 64-MDCT 537by mammography: 35 lesions were proved pathologically
benign and 13 were false negative (11 with dense breast gland-
ular parenchyma and 2 with small lesions less than 1 cm). On
the other hand 59 lesions were diagnosed as malignant by
mammography, 51 of them were proved true (+ve) by
histopathology and 8 lesions were false (+ve) ‘‘5 lesions’’ with
suspected criteria, semi-deﬁned outlines, and 3 lesions showed
foci of micro-calciﬁcation associated with skin thickening and
edema. Poor sensitivity (79%) owing to 11 patients that
showed dense breast with poor diagnostic results (Figs. 1–4
and Tables 2, 5 and 6).
3.4. Ultrasonography diagnosis
According to the primary and secondary signs of malignancy,
classiﬁcation of the lesions was done to a category of benign
and malignant; out of 44 lesions that were diagnosed benign
by U/S.: 33 lesions were proved pathologically benign and 11
lesions were false negative (lesions showed well deﬁned out-
lines and homogenous texture). On the other hand 63 lesions
were diagnosed as malignant by US, 53 of them were proved
true (+ve) by histopathology and 10 lesions were false
(+ve) ‘‘lesions’’ showed poorly deﬁned outlines, non-homoge-
nous echo pattern, with micro-calciﬁcation foci (Figs. 1–4 and
Tables 2, 5 and 6).
64-MDCT diagnosis of breast mass based on analyses of
the morphological parameters as well as the dynamic post-con-
trast data: All detected lesions were classiﬁed as either benign
or malignant lesions.
(a) Morphologic parameters:
The presence of irregular shape with speculated margin was
a sign of malignancy. This was statistically signiﬁcant with
p< 0.0001, and out of 61 lesions that showed ill-deﬁned mar-
gin and diagnosed by MDCT as malignant 59 were proved to
be malignant histopathologically. The 2 false (+ve) ill-deﬁned
enhancing lesions were abscesses. The smooth lobulated mar-
gin was not a sign of benignity, as out of 48 lesions showed
smooth lobulated margin: 32 lesions diagnosed benign by
MDCT, 19 were proved to be benign histopathologically and
3 were false (ve) with pathological result as mucinouscarcinoma. The other 10 lesions were malignant by MDCT
and proved pathologically.
MDCT was superior in micro-calciﬁcation detection, (23
cases) while in mammography, 16 cases shown micro calciﬁca-
tion that was seen in only 9 patients by U/S. The detailed mor-
phological analysis of all lesions was shown in Table 3.
(b) Dynamic post-contrast study:
Timing of enhancement and the pattern of enhancement
were used for lesion characterization; early, peripheral and
heterogonous enhancements were seen mainly in malignant
lesions.
3.5. Time density curve patterns
The washout and plateau patterns were seen mainly in malig-
nant lesions.
According to all collected dynamic MDCT data, out of 42
lesions that were diagnosed benign, 38 lesions were proved
pathologically benign and 4 were false negative. On the other
hand 65 lesions were diagnosed as malignant 60 of them were
proved true (+ve) by histopathology and 5 lesions were false
(+ve) (Figs. 1–4 and Tables 4–6).
3.6. Signs of spread of malignancy (staging)
64 MDCT was found to be superior to mammography and U/
S as an efﬁcient technique in the preoperative assessment and
staging of breast masses.
Surgical decisions for 5 patients were changed from lumpec-
tomy to mastectomy because of the additional information
provided by dynamic MDCT (Table 5).
The most accurate modality in detecting, diagnosing and
staging breast lesions was the 64 MDCT with 91% accuracy
(Table 6).
4. Discussion
Diagnostic procedures are crucial for the early detection of
breast cancer that accounts for approximately 15% of female
cancer death (12).
In this work all patients were complaining of breast lump (s)
with palpable axillary L.Ns in 46 patients. Breast cancer is often
ﬁrst suspected when a lump or change in the breast is found
(13). The most common symptom of breast cancer is a new
lump or mass (14). Kolb et al. stated that a lump detected either
by the patient or by a physician carries a 20% risk of cancer
(15).
Mammography results calculation revealed 79% sensitivity,
81% speciﬁcity and 80% accuracy for mass characterization.
The relatively low sensitivity was due to the non-informative
dense breast in 11 patients. Dense breast tissue can look white
or light gray on a mammogram. This can make mammograms
harder to interpret (13). Mukhtar et al. stated that breast mam-
mography detected 78% of cancer in glandular breast (16),
while Badgwell et al. gave a lower sensitivity of 50% with a
speciﬁcity of 40% which is attributed to several factors includ-
ing: Patient age, breast density, tumor size and location (17).
On the other hand Manisha et al. found that mammography
sensitivity was 100% and speciﬁcity was 97.9%, (18). The
Fig. 1 59-year old female patient, complaining from painless left breast mass. (A) Mammography MLO view shows glandular
parenchyma with poor deﬁnition. (B) Lt. breast US shows hypo-echoic soft tissue mass with well-deﬁned lobulated outlines, echofocal-
lesion. (C–E) Axial CT (pre and +C after 1 and 3 min) shows sizable Lt. Br. mass with smooth micro-lobulation, early heterogeneous
enhancement at 1 min and rapid washout of contrast at 3 min. (F) Coronal (+C) CT showed enhanced mass with no other lesions
detected. (G) 3D images show the enhanced lesion with its vascular supply and angiogenesis. (H) Malignant pattern time density curve
(washout). Histopathology: invasive duct carcinoma.
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Fig. 2 47-year old female patient, complaining from rapidly growing mass at the right breast. (A) Mammography MLO view shows ill-
deﬁned hyper-dense shadows suspicious of malignancy. (B) US breast shows poorly deﬁned hypo-echoic oblong shaped lesion with
posterior shadowing and irregular outlines. (C–E) Axial (pre and +C, 1 and 3 min) CT shows Rt. breast mass with micro-calciﬁcations, at
the non contrast image and early mild enhancement at 1 min with persistence of the contrast at 3 min image. (F) Coronal (+C) shows
another focal lesion with speculated margin. (G) Oblique (+C) shows the two enhanced nodular masses with speculated outlines mainly at
the larger lesion. (H) Time density curve shows plateau pattern. Histopathology: multifocal invasive lobular carcinoma.
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sensitivity was about 82%, speciﬁcity was 77% and accuracy
was 80%. Sorin et al. found that US sensitivity was about
88% (19). Michell depicted US sensitivity of 87%, speciﬁcity
of 92% and accuracy of 89% (20). The sensitivity, speciﬁcity,positive predictive value and negative predictive value for US
were 95%, 94.1%, 95.5%, and 93.75% respectively (21).
We preferred 64 MDCT technique with low dose parame-
ters: This was comparable with Diana et al., who recom-
mended using examination protocols based on setting using
Fig. 3 51-year old female patient complaining from palpable painless masses in Lt. breast: (A) Mammography, CC view showed well-
deﬁned small dense nodular opacities/no calciﬁcations. (B) Lt. breast U/S showed well-deﬁned hypoechoic mass lesions with multiple
atypical axillary LNs. (C–E) Axial 64-MDCT (pre, 1 and 3 min +C) shows Lt. breast irregular nodular lesions with persistent dense
contrast enhancement. (F) 3D image and (G) sagittal image dorsal spine (bone window) showed abnormal bone marrow texture with lytic
bony lesion (arrowed). (H) Time density curve plateau pattern. Histo-pathology: breast lymphoma with nodal and marrow inﬁltrations.
540 M.A.K.A. Wahab, H. Abdel Kareemmodulation for dose reduction to the female breast and pelvis
(22) Low dose MDCT scanning is a feasible imaging technique
for tumor staging before treatment (11). A preliminary study
using low-dose breast CT by Seo et al., demonstrated satisfac-
tory results for breast cancer staging by low dose CT (23).
According to results of this study, MDCT morphologic
data established that the presence of irregular shape with
speculated margin as a sign of malignancy. Non-contrast
MDCT was found to be superior to mammography and U/Sin the detection of micro-calciﬁcation, (23 cases) with
MDCT versus 16 and 9 by mammography and U/S respec-
tively. Micro-calciﬁcation is a hallmark of breast cancer (24).
Inoue et al. found that a speculated margin had a positive pre-
dictive value for malignancy of 99% (25).
This study results documented that in dynamic post-con-
trast MDCT study, early, peripheral and heterogonous
enhancement was seen mainly in malignant lesions. The wash-
out and plateau pattern of the time density curve were seen
Fig. 4 61-year old female patient with history of Lt. mastectomy for breast cancer, complaining of Rt. breast lump: (A) Mammography
magniﬁed MLO view: shows rounded dense suspicious shadow with irregular outlines. (B) Breast U/S shows anechoic cystic lesion with
thick irregular inner walls. (C) Non-contrast axial CT showed Rt. breast focal lesion with irregular outlines. (D) Dynamic (+C) Axial CT
showed cystic lesion with peripheral enhancement. (E) Coronal (3 min +C) CT shows persistent delayed enhancement. (F) Axial (8 min
+C) CT shows persistent delayed mild enhancement. (G) Zoomed (+C) coronal CT showed the cystic lesion with rim enhancement and
related hyper-vascularity. (H) Time density curve with benign pattern (persistent). Histopathology: benign breast abscess.
Table 2 Analysis of the primary diagnose by mammography and U/S compared to histo-pathologic results.
Diagnostic modality Malignant Benign
Mammography 59 (51 true and 8 F +ve) 48 (35 true and 13 F ve)
US 63 (53 true and 10 F +ve) 44 (33 true and 11 F ve)
Histo-pathology 64 43
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Table 3 Morphological analysis of the all lesions in non-
enhanced MDCT.
Morphology analysis Non-enhanced MDCT
Mass lesion
1. Number
–Solitary 94
-Multiple 6
2. Wall deﬁnition
–Well-deﬁned 46
–Ill-deﬁned 61
3. Border
–Lobulated 48
–Speculated 59
Calciﬁcations
–Macro 19
–Micro 23
Secondary signs
–Skin thickening 27
–Nipple changes 13
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ity was 93%, speciﬁcity was 89% and accuracy was about
91%. This is in agreement with Fujita et al. who concluded
that strong enhancement on 1-min images is caused by the
neo-angiogenesis typical of malignant lesions (26) and with
Takase et al. who found that early enhancement was indicativeTable 4 Analysis of the primary diagnose according to morphol
compared to histo-pathologic results.
Diagnostic item No of mali
Morphology 61
Pattern of enhancement 3
Homogenous patchy 11
Peripheral 51
Time of enhancement
Early 61
Late 4
Time density curve
Washout 40
Plateau 25
Rising –
Primary diagnosis by DMDCT (total) 65 (60 true
Histo-pathology diagnosis 64
Table 5 Criteria for malignancy spread for cancer staging in dynam
Findings No. of lesion
Multicentric lesions 4
Multifocal lesions 2
Pectoral muscle and chest wall invasion 3
-axillary LN 59
-others, (supra-clav.-internal mammary, hilar and
mediast.)
9
Bony cage lesions 2
Lung nodules 3
Liver focal lesions 2sign of malignancy with sensitivity of 92% but speciﬁcity was
only 64% (27). The washout or plateau pattern was a predictor
of likelihood of carcinoma. Rim enhancement is highly predic-
tive for malignancy (28,29). The dynamic helical CT-mammo-
gram study of Yamamoto et al. (29) showed 94.6% sensitivity,
58.6% speciﬁcity, 74.7% positive predictive value, 89.4%
negative predictive value and 78.9% overall accuracy (31).
MDCT conﬁrmed a sensitivity, speciﬁcity, and accuracy of
61%, 88% and 71% whereas MRI conﬁrmed a sensitivity,
speciﬁcity and accuracy of 75%, 88% and 80%, respectively
(1).
Results in this series showed that MDCT was superior to
mammography and U/S. For the pre-operative detection of
breast tumors and depiction of tumor invasion; surgical deci-
sion for 8 patients were changed because of the additional
diagnostic information of dynamic MDCT. We prefer examin-
ing the patients by MDCT in the supine position for surgical
simulation. These results were coincidence with Lee et al.
(11) who stated that: to stage the breast cancer (TNM stage),
we should evaluate lymph nodes in the internal mammary,
supra or Infra clavicular areas, and axillae. Mammography
or ultrasonography was limited in evaluating these lymph
nodes (22). Also, Lim (2003) concluded that, for tumor staging
of invasive breast cancers, we should evaluate breasts, lymph
nodes and other organs that were frequent metastatic sites,
such as bones, liver, or lungs (30).
Preoperative MDCT can be performed with the patient in
the supine position that facilitates simultaneous localizationogical and contrast enhancement ﬁndings of dynamic MDCT
gnant lesions No of benign lesions
46
28
9
5
5
37
–
18
24
and 5 false +ve) 42 (38 true and 4 false ve)
43
ic MDCT, mammography and U/S.
s in MDCT No. of lesions in mammography No. of lesions in US
1 2
1 1
1 –
37 57
– 3
– –
– –
– –
Table 6 Statistics of diagnostic accuracy of different imaging modalities.
Imaging modality Mammography (%) Ultrasonography (%) 64 MDCT (%)
Sensitivity 79 82 93
Speciﬁcity 81 77 89
Accuracy 80 80 91
Evaluation of the role of dynamic 64-MDCT 543of the lesion and evaluation of its extent with examination of
the skin and chest wall as well as the lymph nodes.
Therefore 3D MDCT should be considered an accurate pre-
operative imaging technique (27). Surgical plans for six
patients were changed because of the additional information
provided by MDCT (26).
5. Conclusion
According to the results of this study we concluded that
dynamic MDCT is recommended to be as a feasible non inva-
sive accurate imaging tool for the diagnosis and work up in
breast cancer patients.
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